These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 18226346

  • 21. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M.
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [Abstract] [Full Text] [Related]

  • 22. Alteration of adhesion molecule expression and cellular polarity in hepatocellular carcinoma.
    Cao Y, Chang H, Li L, Cheng RC, Fan XN.
    Histopathology; 2007 Oct; 51(4):528-38. PubMed ID: 17880531
    [Abstract] [Full Text] [Related]

  • 23. Histological diagnosis of hepatocellular carcinoma.
    Callea F, Fabbretti G, Brisigotti M, Cozzutto C.
    Ital J Gastroenterol; 1992 Jan; 24(1):50-4. PubMed ID: 1373976
    [Abstract] [Full Text] [Related]

  • 24. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
    Kimura F, Kawamura J, Watanabe J, Kamoshida S, Kawai K, Okayasu I, Kuwao S.
    Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
    [Abstract] [Full Text] [Related]

  • 25. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma.
    Chen Z, Shao JB, Wu W.
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):570-3. PubMed ID: 14607688
    [Abstract] [Full Text] [Related]

  • 26. c-myc overexpression in hepatocarcinogenesis.
    Feitelson MA.
    Hum Pathol; 2004 Nov; 35(11):1299-302. PubMed ID: 15668885
    [No Abstract] [Full Text] [Related]

  • 27. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
    Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T, Aburatani H.
    Gene; 2006 Dec 15; 384():51-61. PubMed ID: 16971064
    [Abstract] [Full Text] [Related]

  • 28. [The expression of NPRL2 protein in hepatocellular carcinoma and its clinical significance].
    Ma YL, Sun JH, Yan F, Li L, Liu L.
    Zhonghua Gan Zang Bing Za Zhi; 2012 May 15; 20(5):390-1. PubMed ID: 22988586
    [No Abstract] [Full Text] [Related]

  • 29. ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study.
    Turhal NS, Bas E, Er O, Aliustaoglu M, Seber S, Dane F, Korkmaz T, Soyuer I, Ozkara S, Celikel C.
    J BUON; 2010 May 15; 15(4):794-6. PubMed ID: 21229648
    [Abstract] [Full Text] [Related]

  • 30. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.
    Mod Pathol; 2003 Jan 15; 16(1):14-21. PubMed ID: 12527708
    [Abstract] [Full Text] [Related]

  • 31. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A.
    Clin Cancer Res; 2004 May 15; 10(10):3509-17. PubMed ID: 15161709
    [Abstract] [Full Text] [Related]

  • 32. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K, Watanabe S, Kuriyama S.
    Int J Oncol; 2002 Apr 15; 20(4):769-75. PubMed ID: 11894123
    [Abstract] [Full Text] [Related]

  • 33. Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading.
    Facoetti A, Ranza E, Grecchi I, Benericetti E, Ceroni M, Morbini P, Nano R.
    Anticancer Res; 2006 Apr 15; 26(5A):3513-6. PubMed ID: 17094475
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions.
    Grigioni WF, Fiorentino M, D'Errico A, Ponzetto A, Crepaldi T, Prat M, Comoglio PM.
    Hepatology; 1995 Jun 15; 21(6):1543-6. PubMed ID: 7768498
    [Abstract] [Full Text] [Related]

  • 35. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I.
    J Gastrointestin Liver Dis; 2008 Dec 15; 17(4):411-7. PubMed ID: 19104702
    [Abstract] [Full Text] [Related]

  • 36. Expression of human aldehyde dehydrogenase-3 associated with hepatocellular carcinoma: promoter regions and nuclear protein factors related to the expression.
    Chang C, Hsu LC, Davé V, Yoshida A.
    Int J Mol Med; 1998 Sep 15; 2(3):333-8. PubMed ID: 9855707
    [Abstract] [Full Text] [Related]

  • 37. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ, DeRose PB, Cohen C.
    Cytometry; 1996 Sep 15; 26(3):198-203. PubMed ID: 8889391
    [Abstract] [Full Text] [Related]

  • 38. Lack of C/EBP alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice [correction of rat] hepatocytes.
    Soriano HE, Kang DC, Finegold MJ, Hicks MJ, Wang ND, Harrison W, Darlington GJ.
    Hepatology; 1998 Feb 15; 27(2):392-401. PubMed ID: 9462636
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection.
    Nam CW, Park NH, Park BR, Shin JW, Jung SW, Na YW, Seo JH.
    J Surg Oncol; 2008 Jun 01; 97(7):567-71. PubMed ID: 18491369
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.